Correlation Between Lion Biotechnologies and Charles Schwab

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lion Biotechnologies and Charles Schwab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lion Biotechnologies and Charles Schwab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lion Biotechnologies and The Charles Schwab, you can compare the effects of market volatilities on Lion Biotechnologies and Charles Schwab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lion Biotechnologies with a short position of Charles Schwab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lion Biotechnologies and Charles Schwab.

Diversification Opportunities for Lion Biotechnologies and Charles Schwab

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lion and Charles is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Lion Biotechnologies and The Charles Schwab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Charles Schwab and Lion Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lion Biotechnologies are associated (or correlated) with Charles Schwab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Charles Schwab has no effect on the direction of Lion Biotechnologies i.e., Lion Biotechnologies and Charles Schwab go up and down completely randomly.

Pair Corralation between Lion Biotechnologies and Charles Schwab

Assuming the 90 days trading horizon Lion Biotechnologies is expected to under-perform the Charles Schwab. In addition to that, Lion Biotechnologies is 1.7 times more volatile than The Charles Schwab. It trades about -0.02 of its total potential returns per unit of risk. The Charles Schwab is currently generating about 0.22 per unit of volatility. If you would invest  6,158  in The Charles Schwab on September 13, 2024 and sell it today you would earn a total of  1,606  from holding The Charles Schwab or generate 26.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lion Biotechnologies  vs.  The Charles Schwab

 Performance 
       Timeline  
Lion Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Charles Schwab 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in The Charles Schwab are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Charles Schwab reported solid returns over the last few months and may actually be approaching a breakup point.

Lion Biotechnologies and Charles Schwab Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lion Biotechnologies and Charles Schwab

The main advantage of trading using opposite Lion Biotechnologies and Charles Schwab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lion Biotechnologies position performs unexpectedly, Charles Schwab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Charles Schwab will offset losses from the drop in Charles Schwab's long position.
The idea behind Lion Biotechnologies and The Charles Schwab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.